Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Stereotaxis Inc's Business Segments
Stereotaxis Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
3
Largest Segment
Disposables Service and Accessories
Total Revenue
$ 8
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Disposables Service and Accessories0%
- Systems36.5%
- Royalty0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Disposables Service and Accessories | $ 11 | - |
| Systems | $ 3 | 36.5% |
| Royalty | - | 0% |
Revenue by Product & Service Category - FY
- Disposables Service and Accessories85.8%
- Systems22.8%
- Royalty0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Disposables Service and Accessories | $ 5 | 85.8% |
| Systems | $ 1 | 22.8% |
| Royalty | - | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Disposables Service and Accessories0%
- Systems36.5%
- Royalty0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Disposables Service and Accessories | $ 11 | - |
| Systems | $ 3 | 36.5% |
| Royalty | - | 0% |
Description of Stereotaxis Inc
Stereotaxis Inc. is a medical device company that specializes in the development and commercialization of robotic systems for the treatment of cardiac arrhythmias. The company was founded in 1990 and is headquartered in St. Louis, Missouri, USA.
At its core, Stereotaxis aims to revolutionize the field of electrophysiology (EP) by leveraging advanced robotics and magnetic navigation technologies. The company's flagship product is the Niobe® ES Robotic System, which enables physicians to perform complex cardiac ablation procedures with increased precision, safety, and efficiency.
The Niobe® system utilizes a unique combination of computerized mapping, imaging, and catheter navigation technologies. It consists of several components, including a robotic arm, a magnetic field generator, and a workstation. The robotic arm is responsible for guiding catheters within the patient's body, while the magnetic field generator generates a magnetic field that interacts with magnets embedded in the catheters. The workstation serves as a control center, allowing the physician to manipulate the robotic arm and visualize real-time images of the patient's heart.
One of the key advantages of the Niobe® system is its ability to deliver precise and reproducible catheter movements, enhancing the physician's ability to navigate through the intricate anatomy of the heart. This precision allows for more targeted delivery of therapy, leading to improved patient outcomes and reduced procedure times. Additionally, the system's remote capabilities enable physicians to perform procedures from a separate control room, reducing their exposure to radiation and providing a more comfortable working environment.
Stereotaxis has gained significant recognition in the medical community and has established partnerships with renowned medical institutions worldwide. The company's technologies have been used in thousands of procedures, demonstrating their clinical efficacy and safety. They have also been shown to lower the incidence of complications associated with traditional manual catheter manipulation.
In addition to the Niobe® system, Stereotaxis offers various accessories and consumables that complement its robotic platform. These include specially designed magnetic catheters, advanced visualization tools, and compatible disposables. By providing a comprehensive suite of products, Stereotaxis aims to streamline the EP workflow, increase treatment consistency, and reduce procedure-related costs.
Furthermore, Stereotaxis invests heavily in research and development to continue advancing the field of robotic EP. The company has an ongoing commitment to innovation and is constantly exploring new applications for its technology, such as remote navigation and integrated imaging solutions.
In summary, Stereotaxis Inc. is a leading medical device company focused on transforming the treatment of cardiac arrhythmias through robotics and magnetic navigation technologies. Its Niobe® Robotic System offers physicians enhanced precision, remote capabilities, and improved patient outcomes. With a strong emphasis on research and development, Stereotaxis continues to drive innovation in the field of electrophysiology.
At its core, Stereotaxis aims to revolutionize the field of electrophysiology (EP) by leveraging advanced robotics and magnetic navigation technologies. The company's flagship product is the Niobe® ES Robotic System, which enables physicians to perform complex cardiac ablation procedures with increased precision, safety, and efficiency.
The Niobe® system utilizes a unique combination of computerized mapping, imaging, and catheter navigation technologies. It consists of several components, including a robotic arm, a magnetic field generator, and a workstation. The robotic arm is responsible for guiding catheters within the patient's body, while the magnetic field generator generates a magnetic field that interacts with magnets embedded in the catheters. The workstation serves as a control center, allowing the physician to manipulate the robotic arm and visualize real-time images of the patient's heart.
One of the key advantages of the Niobe® system is its ability to deliver precise and reproducible catheter movements, enhancing the physician's ability to navigate through the intricate anatomy of the heart. This precision allows for more targeted delivery of therapy, leading to improved patient outcomes and reduced procedure times. Additionally, the system's remote capabilities enable physicians to perform procedures from a separate control room, reducing their exposure to radiation and providing a more comfortable working environment.
Stereotaxis has gained significant recognition in the medical community and has established partnerships with renowned medical institutions worldwide. The company's technologies have been used in thousands of procedures, demonstrating their clinical efficacy and safety. They have also been shown to lower the incidence of complications associated with traditional manual catheter manipulation.
In addition to the Niobe® system, Stereotaxis offers various accessories and consumables that complement its robotic platform. These include specially designed magnetic catheters, advanced visualization tools, and compatible disposables. By providing a comprehensive suite of products, Stereotaxis aims to streamline the EP workflow, increase treatment consistency, and reduce procedure-related costs.
Furthermore, Stereotaxis invests heavily in research and development to continue advancing the field of robotic EP. The company has an ongoing commitment to innovation and is constantly exploring new applications for its technology, such as remote navigation and integrated imaging solutions.
In summary, Stereotaxis Inc. is a leading medical device company focused on transforming the treatment of cardiac arrhythmias through robotics and magnetic navigation technologies. Its Niobe® Robotic System offers physicians enhanced precision, remote capabilities, and improved patient outcomes. With a strong emphasis on research and development, Stereotaxis continues to drive innovation in the field of electrophysiology.
Stereotaxis Inc. is a pioneering healthcare technology company that focuses on the development of innovative robotic systems for the treatment of cardiac arrhythmias. Their main products and services are centered around advanced robotic solutions, enabling minimally invasive procedures within electrophysiology. Below is an extensive overview of the segments, products, and services that Stereotaxis Inc. offers:
Product Segments
1. Robotic Catheter Navigation Systems:
- Stereotaxis is best known for its robotic catheter navigation systems, which allow physicians to perform complex cardiac procedures with high precision and control. The flagship product in this segment is the Niobe ES™ System. This system uses magnetic fields to guide catheters and other devices through the heart, minimizing manual manipulation and enhancing procedural outcomes.
2. Electrophysiology (EP) Catheters:
- The company offers a range of disposable EP catheters designed for use with their robotic systems. These catheters are engineered for precision and flexibility, ensuring that they can navigate complex anatomical structures within the heart.
3. Software Solutions:
- Stereotaxis provides integrated software platforms that facilitate real-time data visualization and procedural management. These software solutions enhance the performance of the robotic systems by allowing for detailed mapping of cardiac anatomy and improved navigation.
4. Imaging Solutions:
- Stereotaxis incorporates advanced imaging technologies into their systems to provide high-resolution visuals of the hearts anatomy. This segment includes integration with fluoroscopy and other imaging modalities to enhance procedural accuracy.
Services Offered
1. Training and Education:
- Stereotaxis places significant emphasis on physician training and education to ensure the safe and effective use of their robotic systems. They provide comprehensive training programs, workshops, and simulation-based learning experiences to familiarize healthcare professionals with the technology.
2. Technical Support and Maintenance:
- The company offers a robust support system for healthcare facilities utilizing their products. This includes technical assistance, system maintenance, and troubleshooting services to ensure that the robotic systems operate optimally.
3. Clinical Support Services:
- Stereotaxis collaborates with healthcare providers in clinical settings to offer support during procedures. This may involve on-site assistance, data collection, and analysis to help optimize patient outcomes.
4. Research and Development Partnerships:
- Stereotaxis works with clinical institutions and research organizations to drive innovation in electrophysiology. They engage in partnerships aimed at developing new applications for their technology, validating clinical outcomes, and expanding their product range through research initiatives.
Market Applications
Stereotaxis primarily focuses on the following therapeutic areas within electrophysiology:
- Atrial Fibrillation (AF): Their robotic systems assist in the ablation of arrhythmias, specifically targeting conditions like AF that require precise catheter navigation.
- Ventricular Tachycardia (VT): The company’s products are also applicable in the treatment of more complex arrhythmias such as VT, enhancing safety and efficacy.
- General Electrophysiology: The technology can be utilized in a variety of electrophysiological procedures, making it versatile for different cardiac conditions.
Conclusion
Through its innovative robotic systems, supportive services, and dedication to advancing cardiac care, Stereotaxis Inc. continues to position itself as a leader in the field of electrophysiology. Their focus on technology integration, coupled with an emphasis on education and clinical support, ensures that they remain at the forefront of advancements in cardiac treatment for arrhythmias.
Product Segments
1. Robotic Catheter Navigation Systems:
- Stereotaxis is best known for its robotic catheter navigation systems, which allow physicians to perform complex cardiac procedures with high precision and control. The flagship product in this segment is the Niobe ES™ System. This system uses magnetic fields to guide catheters and other devices through the heart, minimizing manual manipulation and enhancing procedural outcomes.
2. Electrophysiology (EP) Catheters:
- The company offers a range of disposable EP catheters designed for use with their robotic systems. These catheters are engineered for precision and flexibility, ensuring that they can navigate complex anatomical structures within the heart.
3. Software Solutions:
- Stereotaxis provides integrated software platforms that facilitate real-time data visualization and procedural management. These software solutions enhance the performance of the robotic systems by allowing for detailed mapping of cardiac anatomy and improved navigation.
4. Imaging Solutions:
- Stereotaxis incorporates advanced imaging technologies into their systems to provide high-resolution visuals of the hearts anatomy. This segment includes integration with fluoroscopy and other imaging modalities to enhance procedural accuracy.
Services Offered
1. Training and Education:
- Stereotaxis places significant emphasis on physician training and education to ensure the safe and effective use of their robotic systems. They provide comprehensive training programs, workshops, and simulation-based learning experiences to familiarize healthcare professionals with the technology.
2. Technical Support and Maintenance:
- The company offers a robust support system for healthcare facilities utilizing their products. This includes technical assistance, system maintenance, and troubleshooting services to ensure that the robotic systems operate optimally.
3. Clinical Support Services:
- Stereotaxis collaborates with healthcare providers in clinical settings to offer support during procedures. This may involve on-site assistance, data collection, and analysis to help optimize patient outcomes.
4. Research and Development Partnerships:
- Stereotaxis works with clinical institutions and research organizations to drive innovation in electrophysiology. They engage in partnerships aimed at developing new applications for their technology, validating clinical outcomes, and expanding their product range through research initiatives.
Market Applications
Stereotaxis primarily focuses on the following therapeutic areas within electrophysiology:
- Atrial Fibrillation (AF): Their robotic systems assist in the ablation of arrhythmias, specifically targeting conditions like AF that require precise catheter navigation.
- Ventricular Tachycardia (VT): The company’s products are also applicable in the treatment of more complex arrhythmias such as VT, enhancing safety and efficacy.
- General Electrophysiology: The technology can be utilized in a variety of electrophysiological procedures, making it versatile for different cardiac conditions.
Conclusion
Through its innovative robotic systems, supportive services, and dedication to advancing cardiac care, Stereotaxis Inc. continues to position itself as a leader in the field of electrophysiology. Their focus on technology integration, coupled with an emphasis on education and clinical support, ensures that they remain at the forefront of advancements in cardiac treatment for arrhythmias.